semaglutide getting banned Compounded "semaglutide" is not FDA-approved FBI issues safety warning about

Additionally, the treatment can cause side effects such as acne, breast enlargement, and mood changes, affecting sexual function and libido

What You Need to Know About Tirzepatide Tirzepatide acts by stimulating two hormonal pathways naturally occurring in your body: GLP-1 and GIP

This drug mimics a natural hormone in the body that helps manage hunger and sugar levels

Whether dual incretin receptor agonism can meaningfully exceed current cardioprotective thresholds remains uncertain

October 3, 2024: Novo Nordisks New Weight Loss Drug Amycretin Shows Promising Early Results The defendant in the Wegovy lawsuit, Novo Nordisk, has announced that its new weight loss drug, amycretin, has been marked as safe and tolerable for patients

In October 2025, authorities in the United Kingdom seized illegal weight-loss drugs in a factory